Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Yashira L. Negrón Abril, Irma Fernández, Jun Young Hong, Ying‐Ling Chiang, Dennis A. Kutateladze, Qingjie Zhao, Min Yang, Jing Hu, Sushabhan Sadhukhan, Bo Li, Bin He, Brenna C. Remick, Jessica Jingyi Bai, James Mullmann, Fangyu Wang, Viviana I. Maymí, Ravi Dhawan, Johan Auwerx, Teresa Southard, Richard A. Cerione, Hening Lin, Robert S. Weiss